Subscribe to Newsletter

May 2020 Issue of The Medicine Maker

In this month’s issue of The Small Molecule Manufacturer, we explore how pharma companies are working to improve pediatric drug formulations. Guia Bertuzzi, Product Manager for Granulation at IMA Active, Italy, argues that companies must choose granulation machinery that will stand the test of time while meeting their QbD and PAT requirements in Inside the Medicine Machine. In addition, we find out how pharmaceutical companies can use digital technologies to their advantage amidst the COVID-19 pandemic, and speak to Tom Moody, VP of Technology Development and Commercialization at Almac, UK, about his career spent striving for pharmaceutical and cross-disciplinary excellence.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Manufacture Packaging

Prototyping for Success

| Maryam Mahdi

New blister cavity designs become a rapid reality with additive manufacturing.

Business & Regulation Digital Technologies

Artificial Impact

| Maryam Mahdi

What role does artificial intelligence (AI) play in R&D?

Business & Regulation Business Practice

COVID-19 in Brief

| Maryam Mahdi

What’s new in business?

Discovery & Development Drug Discovery

Stepping Inside Drug Design

| Maryam Mahdi

Scientists use VR to help determine the drugs of the future.

Discovery & Development Drug Discovery

An Orange a Day...

| Maryam Mahdi

A citrus flavonoid found in sweet oranges has been show to reduce obesity in mice and lessen associated complications.

Discovery & Development Drug Delivery

The Mitochondrial Trojan Horse

| Maryam Mahdi

A metal-organic framework could help reduce drug doses needed to kill cancer cells by smuggling drugs into mitochondria.

Manufacture Small Molecules

Weighing Up Granulation Options

| Andreas Znidar

Whether wet or dry, high shear or single pot, the best granulation method is the one that matches your operational needs

Manufacture Formulation

Closing the Treatment Gap

| Maryam Mahdi

A dispersible tablet could open up treatment options for pediatric patients, according to Harmony Grages, Chief Medical Officer at ViiV Healthcare.

Manufacture Formulation

Natural Concern

| Maryam Mahdi

How can the lives of children affected by Chagas disease be improved?

Manufacture Formulation

A Changing Landscape

| Maryam Mahdi

Matt Ling and Andrew Parker, both at Catalent, walks us through the most important developments in pediatric drug manufacturing.

Manufacture Ingredients

Pediatric Formulation 101

| Ralph N. Landau

What dosage forms work best for children?

Manufacture Process Control

The Future of Fluid Bed Granulation

| Maryam Mahdi

Guia Bertuzzi, Product Manager for Granulation at IMA Active, Italy, discusses the evolution of granulation machinery.

Business & Regulation Business Practice

COVID-19: Navigating the New Norm

| Maryam Mahdi

Under pressure to deliver results, how can the pharmaceutical industry handle the current COVID-19 crisis to help patients around the world?

Business & Regulation Profession

Achieving Excellence

| Maryam Mahdi

Sitting Down With… Tom Moody, VP of Technology Development and Commercialization at Almac, Craigavon, UK.

Other issues of 2020